CRM-646

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCRM-646
Drug Alias NameCRM-646
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionHeparinase inhibitors
TargetsHeparinase
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFar East
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A